We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Tecogen Inc
TGEN
$63.1M
| $73K | ﹤0.01% |
+22,797
| New | +$74K |
2017 Q3
0 quarters
|
|
|
DAG
2152
DELISTED
DB Agriculture Double Long ETN due April 1, 2038
DAG
| $73K | ﹤0.01% |
+24,079
| New | +$77.9K |
2017 Q3
0 quarters
|
|
2153
DELISTED
CASI Pharmaceuticals
CASI
| $72K | ﹤0.01% |
+4,079
| New | +$47.6K |
2017 Q3
0 quarters
|
|
2154
US Global Investors
GROW
$33.5M
| $72K | ﹤0.01% |
+33,656
| New | +$50K |
2017 Q3
0 quarters
|
|
2155
Virtus Convertible & Income Fund
NCV
$334M
| $72K | ﹤0.01% |
+2,520
| New | +$71K |
2017 Q3
0 quarters
|
|
|
SFUN
2156
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $72K | ﹤0.01% |
+355
| New | +$62.8K |
2017 Q3
0 quarters
|
|
2157
Lattice Semiconductor
LSCC
$14.7B
| $71K | ﹤0.01% |
+13,541
| New | +$82.4K |
2017 Q3
0 quarters
|
|
2158
DELISTED
MANNING & NAPIER, INC.
MN
| $71K | ﹤0.01% |
+17,911
| New | +$68.5K |
2017 Q3
0 quarters
|
|
|
SVA
2159
DELISTED
Sinovac Biotech, Ltd
SVA
| $71K | ﹤0.01% |
+10,119
| New | +$69.1K |
2017 Q3
0 quarters
|
|
2160
Viking Therapeutics
VKTX
$3.2B
| $70K | ﹤0.01% |
+36,588
| New | +$41.6K |
2017 Q3
0 quarters
|
|
|
ADYX
2161
DELISTED
Adynxx Inc
ADYX
| $70K | ﹤0.01% |
+3,206
| New | +$66.3K |
2017 Q3
0 quarters
|
|
|
DXTR
2162
DELISTED
Dextera Surgical Inc.
DXTR
| $70K | ﹤0.01% |
+255,494
| New | +$73.5K |
2017 Q3
0 quarters
|
|
2163
Fortress Biotech
FBIO
$62.4M
| $69K | ﹤0.01% |
+1,044
| New | +$70.4K |
2017 Q3
0 quarters
|
|
2164
DELISTED
Chimerix, Inc.
CMRX
| $69K | ﹤0.01% |
+13,228
| New | +$65.1K |
2017 Q3
0 quarters
|
|
|
TLGT
2165
DELISTED
Teligent, Inc
TLGT
| $68K | ﹤0.01% |
+1,018
| New | +$74.6K |
2017 Q3
0 quarters
|
|
|
TGA
2166
DELISTED
Transglobe Energy Corp
TGA
| $67K | ﹤0.01% |
+48,703
| New | +$62.1K |
2017 Q3
0 quarters
|
|
|
ARLZ
2167
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $67K | ﹤0.01% |
+29,468
| New | +$39.4K |
2017 Q3
0 quarters
|
|
2168
Larimar Therapeutics
LRMR
$207M
| $66K | ﹤0.01% |
+1,572
| New | +$65.4K |
2017 Q3
0 quarters
|
|
2169
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $66K | ﹤0.01% |
+2,824
| New | +$31.7K |
2017 Q3
0 quarters
|
|
|
DTEA
2170
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $66K | ﹤0.01% |
+15,559
| New | +$81.4K |
2017 Q3
0 quarters
|
|
|
OMNT
2171
DELISTED
Ominto, Inc. Common Stock
OMNT
| $66K | ﹤0.01% |
+14,719
| New | +$85.4K |
2017 Q3
0 quarters
|
|
|
TEUM
2172
DELISTED
Pareteum Corporation
TEUM
| $66K | ﹤0.01% |
+43,580
| New | +$43.4K |
2017 Q3
0 quarters
|
|
2173
BNY Mellon High Yield Strategies Fund
DHF
$161M
| $65K | ﹤0.01% |
+18,362
| New | +$64.4K |
2017 Q3
0 quarters
|
|
2174
Obsidian Energy
OBE
$799M
| $65K | ﹤0.01% |
+8,861
| New | +$65.6K |
2017 Q3
0 quarters
|
|
2175
Wipro
WIT
$19.3B
| $65K | ﹤0.01% |
+30,672
| New | +$67.2K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.